Deciphering the role of insulin-like growth factor-I receptor in trastuzumab resistance
{{output}}
Resistance to the HER2-targeted antibody trastuzumab is a major clinical concern in the treatment of HER2-overexpressing metastatic breast cancer. Increased expression or signaling of the insulin-like growth factor-I receptor (IGF-IR) has been reported in a su... ...
